Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 31-May-24 4:15 PM View:  | Taysha Gene Therapies, Inc. (TSHA) | 29-May-24 | Grant | 49,220 | -- | -- | 100% 0 to 49.22K | |
| 05-Mar-24 4:10 PM View: | Intellia Therapeutics, Inc. (NTLA) | 01-Mar-24 | Grant | 37,966 | -- | -- | 86% 43.93K to 81.89K | |
| 10-Jan-24 4:15 PM View: | Intellia Therapeutics, Inc. (NTLA) | 08-Jan-24 | Sale (Planned) | 2,275 | $28.87 | $65,681.70 | (5%) 46.2K to 43.93K | |
| 05-Jan-24 4:50 PM View: | Intellia Therapeutics, Inc. (NTLA) | 03-Jan-24 | Sale | 5,532 | $29.46 | $162,973.00 | (11%) 51.73K to 46.2K | |
| 03-Jan-24 5:35 PM View: | Intellia Therapeutics, Inc. (NTLA) | 01-Jan-24 | Option Exercise | 3,500 | -- | -- | 7% 48.23K to 51.73K | |
| 03-Mar-23 5:14 PM View: | Intellia Therapeutics, Inc. (NTLA) | 01-Mar-23 | Grant | 29,938 | -- | -- | 170% 17.63K to 47.57K | |
| 06-Jan-23 5:39 PM View: | Intellia Therapeutics, Inc. (NTLA) | 05-Jan-23 | Sale (Planned) | 2,330 | $38.48 | $89,658.90 | (12%) 19.96K to 17.63K | |
| 06-Jan-23 5:39 PM View: | Intellia Therapeutics, Inc. (NTLA) | 04-Jan-23 | Sale | 2,508 | $37.21 | $93,322.70 | (11%) 22.47K to 19.96K | |
| 04-Jan-23 8:38 PM View: | Intellia Therapeutics, Inc. (NTLA) | 01-Jan-23 | Option Exercise | 3,500 | -- | -- | 18% 18.97K to 22.47K | |
| 03-Mar-22 8:03 PM View: | Intellia Therapeutics, Inc. (NTLA) | 01-Mar-22 | Grant | 13,816 | -- | -- | 287% 4.82K to 18.63K | |
| 03-Mar-22 8:03 PM View: | Intellia Therapeutics, Inc. (NTLA) | 01-Jan-22 | Option Exercise | 3,500 | -- | -- | 142% 2.46K to 5.96K | |
| 03-Mar-22 8:03 PM View: | Intellia Therapeutics, Inc. (NTLA) | 01-Jan-22 | Option Sale | 1,148 | $112.25 | $128,863.00 | (19%) 5.96K to 4.82K | |
| 01-Sep-21 7:34 PM View: | Intellia Therapeutics, Inc. (NTLA) | 30-Aug-21 | Option Exercise | 97,000 | $14.01 | $1,359,300.00 | 4057% 2.39K to 99.39K | |
| 01-Sep-21 7:34 PM View: | Intellia Therapeutics, Inc. (NTLA) | 30-Aug-21 | Market Option Sale (Planned) | 97,000 | $154.82 | $15,018,100.00 | (98%) 99.39K to 2.39K | |
| 06-Aug-21 6:19 PM View: | Intellia Therapeutics, Inc. (NTLA) | 04-Aug-21 | Option Exercise | 26,000 | $13.40 | $348,400.00 | 1087% 2.39K to 28.39K | |
| 06-Aug-21 6:19 PM View: | Intellia Therapeutics, Inc. (NTLA) | 04-Aug-21 | Market Option Sale (Planned) | 26,000 | $138.24 | $3,594,360.00 | (92%) 28.39K to 2.39K |